RNU6-334P

Across TCGA pan-cancer cohorts, RNU6-334P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-334P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU6-334P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-334P expression acts as an unfavorable survival marker.

BLCA, LIHC, and BRCA are the cancer types where RNU6-334P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.141	0.687	.003	54	view →
LIHC	OS	Tertile	All	0.071	0.786	<.001	54	view →
BRCA	OS	Tertile	II,III,IV	0.165	0.567	.003	18	view →
ESCA	DFS	Tertile	All	0.338	0.518	.035	18	view →
UCEC	DFS	Tertile	All	0.123	0.648	.031	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-334P–BLCA (OS)

Open the BLCA breakdown →